2614-06-4
2614-06-4
Chemical Structure
(R)-Thalidomide
Synonym(s): (R)-(+)-Thalidomide
- CAS No.: 2614-06-4
- Formula:C13H10N2O4
- Molecular Weight:258.23
IUPAC Name: (R)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
InChIKey: UEJJHQNACJXSKW-SECBINFHSA-N
SMILES: O=C1N([C@H](CC2)C(NC2=O)=O)C(C3=C1C=CC=C3)=O
Biological Activity: (R)-Thalidomide ((R)-(+)-Thalidomide) is the R-enantiomer of Thalidomide. (R)-Thalidomide has psychomotor stabilizing properties[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(R)-Thalidomide | 99.80% | (R)-Thalidomide ((R)-(+)-Thalidomide) is the R-enantiomer of Thalidomide. (R)-Thalidomide has psychomotor stabilizing properties. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Murphy S, et al. Enantioselectivity of thalidomide serum and tissue concentrations in a rat glioma model and effects of combination treatment with cisplatin and BCNU. J Pharm Pharmacol. 2007 Jan;59(1):105-14. [Content Brief]
- [2]. Eriksson T, et al. Intravenous formulations of the enantiomers of thalidomide: pharmacokinetic and initial pharmacodynamic characterization in man. J Pharm Pharmacol. 2000 Jul;52(7):807-17. [Content Brief]
Keywords
